Literature DB >> 1124884

Pulmonary function evaluation of the lung resection candidate: a prospective study.

G N Olsen, A J Block, E W Swenson, J R Castle, J W Wynne.   

Abstract

In the past, preoperative pulmonary function abnormalities have identified a group of patients in danger of postoperative cardiorespiratory morbidity and mortality. We selected a group of 56 patients, each of whom had a lung mass and had demonstrated significant abnormalities in screening pulmonary function. By using temporary unilateral pulmonary artery occlusion and quantitative macroaggregate lung scanning, we then studied these patients for split pulmonary function. Those patients whose noncancerous lung had a calculated forced expiratory volume in 1 sec greater than 800 ml and a circulation that could accommodate all of the cardiac output without producing hypertension or arterial hypoxemia were offered thoracotomy. Of the 56 patients, we judged 6 to be physiologically inoperable and did not offer surgery. Another 4 patients were not offered surgery, and 4 refused surgery. Forty-two patients underwent surgical exploration-of these, 17 then had a pneumonectomy and 13, a lobectomy. Of the 30 patients resected, 6 died in surgery (4 from respiratory insufficiency). These cardiorespiratory mortality rates (neumonectomy, 17.6 per cent; lobectomy, 7.7 per cent) are lower than those reported previously when patients had equivalent pulmonary function abnormality. A follow-up of 49 of 56 patients revealed that 59 per cent of the patients undergoing either pneumonectomy or lobectomy were still living 1 to 3 years after the resection. Our results suggested that the preoperative testing of split pulmonary function permitted an attempt at surgery in patients who might otherwise be considered inoperable by history, physical examination, screening pulmonary function tests alone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124884     DOI: 10.1164/arrd.1975.111.4.379

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  Choice of treatment in operable lung cancer.

Authors: 
Journal:  Br Med J       Date:  1979-04-14

Review 3.  Preoperative evaluation of pulmonary risk factors.

Authors:  D N Mohr; J R Jett
Journal:  J Gen Intern Med       Date:  1988 May-Jun       Impact factor: 5.128

4.  Krypton-81m ventilation studies as a parameter for lung capacity after lobectomy.

Authors:  M C Bins; A M Wever; E K Pauwels; E A van der Velde
Journal:  Eur J Nucl Med       Date:  1984

5.  Functional evaluations for pulmonary resection for lung cancer in octogenarians. Investigation from postoperative complications.

Authors:  T Tanita; Y Hoshikawa; T Tabata; M Noda; M Handa; H Kubo; M Chida; S Suzuki; S Ono; S Fujimura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-06

6.  Is this patient fit for thoracotomy and resection of lung tissue?

Authors:  S D Thomas; P D Berry; G N Russell
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

7.  Retrospective investigation of pulmonary resection in patients with high total pulmonary vascular resistance during preoperative unilateral pulmonary artery occlusion.

Authors:  Yoshinori Nagamatsu; Akira Ohkita; Norman Y Kimura; Goichi Nakayama; Ryozou Hayashida; Hideaki Yamana; Kazuo Shirouzu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-05-15

Review 8.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

Review 9.  Pulmonary pathophysiology and lung mechanics in anesthesiology: a case-based overview.

Authors:  Marcos F Vidal Melo; Guido Musch; David W Kaczka
Journal:  Anesthesiol Clin       Date:  2012-09-01

10.  Selection of pulmonary resection procedures to avoid postoperative complications.

Authors:  Yoshinori Nagamatsu; Kanetaka Maeshiro; Masaki Kashihara; Yasunori Iwasaki; Ichirou Shima; Hideaki Yamana; Kazuo Shirouzu
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.